Alport Syndrome
📧 Sign up to get email alerts when something new happens for Alport Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: ASF Alport Patient Registry
The Alport Syndrome Foundation-sponsored clinical trial is updating on the ASF Alport Patient Registry, which is currently recruiting to col…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety [Phase 2]
Phase 2 EXACT study evaluating Exaluren for Alport syndrome (X-linked and autosomal recessive) is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: BAY3401016; Biomarker Study Alport [Phase 2]
A Phase 2 biomarker study of BAY3401016 for Alport syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases [Phase 2]
Travere Therapeutics is running a phase 2 pediatric trial of sparsentan for proteinuric glomerular diseases, including Focal Segmental Glome…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)
This entry provides information about the RaDiCo Eurbio-Alport study, a RaDiCo cohort investigation sponsored by INSERM, which is currently …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Atrasentan in Patients With Proteinuric Glomerular Diseases [Phase 2]
Phase 2 trial of atrasentan for proteinuric glomerular diseases is active but not recruiting, including IgA nephropathy, Focal segmental glo…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
The Alport Therapy Registry is a European research initiative to delay renal failure in Alport syndrome and is currently recruiting particip…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome [Phase 2, Phase 3]
The document describes an ongoing Phase 2/Phase 3 clinical trial evaluating human umbilical cord mesenchymal stem cells for Alport syndrome,…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Effects of Dapagliflozin on Progression of Alport Syndrome
Clinical trial update on the effects of dapagliflozin for progression of Alport syndrome; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
A multi-center feasibility study investigating Alport Syndrome has completed.